Flu shot study for adults over 75
Part of Infections, Lungs & breathing clinical trials.
This study looks at getting an influenza (flu) vaccine in adults age 75 and older. It may help doctors understand how to safely give flu shots to older adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult older than 75 years
- You must not have a known allergy to eggs or to a flu vaccine
- You should not have active cancer
- You should not currently be on cancer treatments like chemotherapy or radiation
- You should not have certain active immune/inflammatory conditions (like rheumatoid arthritis, Crohn’s, or ulcerative colitis)
- You should not be using immune-changing medicines, such as oral steroids (prednisone) or drugs like methotrexate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new seasonal flu shot for people aged 60 and older. It aims to see if the vaccine is safe and how well it produces a protective immune response in older adults.
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
This study checks the safety of a flu vaccine called Efluelda Tetra in adults aged 65 and older. If you are getting this vaccine, you may be able to join and help monitor its safety.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This study tests a new flu vaccine to see how well it helps the body fight off the flu. It is for generally healthy adults aged 18 to 59 who have not had the flu recently.
This trial tests an experimental flu shot that includes an adjuvant (an ingredient that boosts the immune response). It aims to see if the shot is safe and how well it works in adults. Participation lasts for a few months and involves blood tests and a review of any side effects.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.